Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.828 CHF | +4.37% |
|
+18.65% | -60.51% |
01:35am | DocMorris Wins Extension for CardLink Product Use in Germany | MT |
01:06am | DocMorris AG - Gematik extends Cardlink approval until January 2027 | RE |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1.48B | 1.73B | 1.61B | 969M | 1.02B | |||||
Other Revenues, Total | - | - | - | - | - | |||||
Total Revenues | 1.48B | 1.73B | 1.61B | 969M | 1.02B | |||||
Cost of Goods Sold, Total | 1.24B | 1.47B | 1.36B | 766M | 801M | |||||
Gross Profit | 241M | 260M | 246M | 203M | 217M | |||||
Selling General & Admin Expenses, Total | 148M | 153M | 162M | 114M | 104M | |||||
Depreciation & Amortization - (IS) | 38.62M | 50.44M | 54.88M | 43.44M | 45.58M | |||||
Amortization of Goodwill and Intangible Assets - (IS) | - | - | - | - | - | |||||
Other Operating Expenses | 182M | 250M | 179M | 127M | 170M | |||||
Other Operating Expenses, Total | 369M | 454M | 396M | 285M | 320M | |||||
Operating Income | -127M | -194M | -150M | -81.19M | -103M | |||||
Interest Expense, Total | -14.73M | -16.19M | -17.73M | -19.14M | -19.54M | |||||
Interest And Investment Income | 1.36M | 579K | 606K | 3.21M | 2.53M | |||||
Net Interest Expenses | -13.37M | -15.61M | -17.12M | -15.92M | -17.01M | |||||
Income (Loss) On Equity Invest. | -3.3M | -5.72M | -156K | -712K | -205K | |||||
Currency Exchange Gains (Loss) | 2.15M | -7.48M | -12.35M | -24.45M | 4.19M | |||||
Other Non Operating Income (Expenses) | -1.02M | -1.25M | -1.13M | -804K | -416K | |||||
EBT, Excl. Unusual Items | -143M | -224M | -181M | -123M | -117M | |||||
Restructuring Charges | - | - | - | - | - | |||||
Merger & Related Restructuring Charges | -1.1M | -313K | -100K | - | - | |||||
Gain (Loss) On Sale Of Investments | -41K | -15K | 2.51M | 6.46M | 438K | |||||
Gain (Loss) On Sale Of Assets | - | - | - | - | 13.66M | |||||
Asset Writedown | -635K | -706K | -7.75M | -1.42M | -323K | |||||
Other Unusual Items | 11.33M | -1.7M | 16.68M | -618K | - | |||||
EBT, Incl. Unusual Items | -133M | -227M | -170M | -119M | -103M | |||||
Income Tax Expense | 2.44M | -949K | 1.25M | -1.09M | -5.5M | |||||
Earnings From Continuing Operations | -136M | -226M | -171M | -118M | -97.25M | |||||
Earnings Of Discontinued Operations | - | - | - | 200M | - | |||||
Net Income to Company | -136M | -226M | -171M | 82.28M | -97.25M | |||||
Minority Interest | -51K | - | - | - | - | |||||
Net Income - (IS) | -136M | -226M | -171M | 82.28M | -97.25M | |||||
Net Income to Common Incl Extra Items | -136M | -226M | -171M | 82.28M | -97.25M | |||||
Net Income to Common Excl. Extra Items | -136M | -226M | -171M | -118M | -97.25M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | -14.95 | -23.4 | -15.88 | 7.05 | -8.25 | |||||
Basic EPS - Continuing Operations | -14.95 | -23.4 | -15.88 | -10.07 | -8.25 | |||||
Basic Weighted Average Shares Outstanding | 9.08M | 9.65M | 10.78M | 11.67M | 11.79M | |||||
Net EPS - Diluted | -14.95 | -23.4 | -15.88 | 7.05 | -8.25 | |||||
Diluted EPS - Continuing Operations | -14.95 | -23.4 | -15.88 | -10.07 | -8.25 | |||||
Diluted Weighted Average Shares Outstanding | 9.08M | 9.65M | 10.78M | 11.67M | 11.79M | |||||
Normalized Basic EPS | -9.84 | -14.51 | -10.51 | -6.59 | -6.18 | |||||
Normalized Diluted EPS | -9.84 | -14.51 | -10.51 | -6.59 | -6.18 | |||||
Dividend Per Share | - | - | - | - | - | |||||
Payout Ratio | - | - | - | - | - | |||||
Supplemental Items | ||||||||||
EBITDA | -114M | -178M | -132M | -65.26M | -88.69M | |||||
EBITA | -121M | -186M | -143M | -74.2M | -96.33M | |||||
EBIT | -127M | -194M | -150M | -81.19M | -103M | |||||
EBITDAR | -110M | -173M | -126M | -60.46M | -84.59M | |||||
Effective Tax Rate - (Ratio) | -1.83 | 0.42 | -0.73 | 0.92 | 5.36 | |||||
Total Current Taxes | 1.75M | 727K | 1.94M | -6K | 259K | |||||
Total Deferred Taxes | 687K | -1.68M | -694K | -1.08M | -5.76M | |||||
Normalized Net Income | -89.28M | -140M | -113M | -76.92M | -72.83M | |||||
Interest on Long-Term Debt | 1.25M | 1.25M | 1.15M | 1.03M | 915K | |||||
Non-Cash Pension Expense | -430K | -2.3M | -137K | -936K | 40K | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | - | - | - | - | - | |||||
Selling and Marketing Expenses | - | - | - | - | - | |||||
Net Rental Expense, Total | 4.9M | 4.88M | 6.89M | 4.8M | 4.1M | |||||
Imputed Operating Lease Interest Expense | 1.3M | 1.2M | 1.85M | 1.71M | 1.99M | |||||
Imputed Operating Lease Depreciation | 3.6M | 3.68M | 5.04M | 3.09M | 2.11M | |||||
Stock-Based Comp., COGS (Total) | - | - | - | - | - | |||||
Stock-Based Comp., SG&A Exp. (Total) | 17.14M | 8.56M | 4.2M | 3.93M | 3.18M | |||||
Stock-Based Comp., Other (Total) | - | - | - | - | - | |||||
Total Stock-Based Compensation | 17.14M | 8.56M | 4.2M | 3.93M | 3.18M |
- Stock Market
- Equities
- ROSE Stock
- Financials DocMorris AG
- Income Statement
Select your edition
All financial news and data tailored to specific country editions